| [1] |
Diez-Sampedro A, Hirayama BA, Osswald C, et al. A glucose sensor hiding in a family of transporters[J]. Proc Natl Acad Sci U S A, 2003,100(20): 11753-11758.
|
| [2] |
Kothinti RK, Blodgett AB, North PE, et al. A novel SGLT is expressed in the human kidney[J]. Eur J Pharmacol, 2012, 690(1-3): 77-83.
|
| [3] |
Codogno P, Meijer A J. Autophagy: a potential link between obesity and insulin resistance[J]. Cell Metab, 2010,11(6): 449-451.
|
| [4] |
Song P, Onishi A, Koepsell H, et al. Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus[J]. Expert Opinion on Therapeutic Targets, 2016, 20(9): 1109-1125.
|
| [5] |
Harada N, Inagaki N. Role of sodium-glucose transporters in glucose uptake of the intestine and kidney[J]. J Diabetes Investig, 2012, 3(4): 352-353.
|
| [6] |
Gorboulev V, Schurmann A, Vallon V, et al. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion[J]. Diabetes, 2012, 61(1): 187-196.
|
| [7] |
Chaudhry RM, Garg A, Abdelfatah M M, et al. Lack of functionally active sweet taste receptors in the jejunum in vivo in the rat[J]. J Surg Res, 2013, 183(2): 606-611.
|
| [8] |
Ramalingam L, Menikdiwela K, LeMieux M, et al. The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance[J]. Biochim Biophys Acta Mol Basis Dis, 2017, 1863(5): 1106-1114.
|
| [9] |
Roder PV, Geillinger KE, Zietek TS, et al. The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing[J]. PLoS One, 2014, 9(2): e89977.
|
| [10] |
Vincent KM, Sharp JW, Raybould HE. Intestinal glucose-induced calcium-calmodulin kinase signaling in the gut-brain axis in awake rats[J]. Neurogastroenterol Motil, 2011, 23(7): e282-e293.
|
| [11] |
Dunham I, Shimizu N, Roe BA, et al. The DNA sequence of human chromosome 22[J]. Nature, 1999, 402(6761): 489-495.
|
| [12] |
Sotak M, Marks J, Unwin RJ. Putative tissue location and function of the SLC5 family member SGLT3[J]. Exp Physiol, 2017, 102(1): 5-13.
|
| [13] |
Diez-Sampedro A, Hirayama BA, Osswald C, et al. A glucose sensor hiding in a family of transporters[J]. Proc Natl Acad Sci U S A, 2003, 100(20): 11753-11758.
|
| [14] |
Lee EY, Kaneko S, Jutabha P, et al. Distinct action of the alpha-glucosidase inhibitor miglitol on SGLT3, enteroendocrine cells, and GLP1 secretion[J]. J Endocrinol, 2015, 224(3): 205-214.
|
| [15] |
Ly T, Ahmad Y, Shlien A, et al. A proteomic chronology of gene expression through the cell cycle in human myeloid leukemia cells[J]. Elife, 2014, 3: e1630.
|
| [16] |
Song P, Onishi A, Koepsell H, et al. Sodium glucose cotransporter SGLT1 as a therapeutic target in diabetes mellitus[J]. Expert Opin Ther Targets, 2016, 20(9): 1109-1125.
|
| [17] |
Chaudhry RM, Garg A, Abdelfatah MM, et al. Lack of functionally active sweet taste receptors in the jejunum in vivo in the rat[J]. J Surg Res, 2013, 183(2): 606-611.
|
| [18] |
Roder PV, Geillinger KE, Zietek TS, et al. The role of SGLT1 and GLUT2 in intestinal glucose transport and sensing[J]. PLoS One, 2014, 9(2): e89977.
|
| [19] |
Pal A, Rhoads DB, Tavakkoli A. Foregut exclusion disrupts intestinal glucose sensing and alters portal nutrient and hormonal milieu[J]. Diabetes, 2015, 64(6): 1941-1950.
|
| [20] |
Sotak M, Marks J, Unwin RJ. Putative tissue location and function of the SLC5 family member SGLT3[J]. Exp Physiol, 2017, 102(1): 5-13.
|
| [21] |
Bouret S, Levin BE, Ozanne SE. Gene-environment interactions controlling energy and glucose homeostasis and the developmental origins of obesity[J]. Physiol Rev, 2015, 95(1): 47-82.
|
| [22] |
Xia J, He Q, He M, et al. Residual Gastric Dilatation Interferes with Metabolic Improvements Following Sleeve Gastrectomy by Upregulating the Expression of Sodium-Glucose Cotransporter-1[J]. Obes Surg, 2019, 29(10): 3324-3333.
|
| [23] |
Fujita Y, Kojima H, Hidaka H, et al. Increased intestinal glucose absorption and postprandial hyperglycaemia at the early step of glucose intolerance in Otsuka Long-Evans Tokushima Fatty rats[J]. Diabetologia, 1998, 41(12): 1459-1466.
|
| [24] |
van Stee MF, de Graaf AA, Groen AK. Actions of metformin and statins on lipid and glucose metabolism and possible benefit of combination therapy[J]. Cardiovasc Diabetol, 2018, 17(1): 94.
|
| [25] |
Cobbina E, Akhlaghi F. Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters[J]. Drug Metab Rev, 2017, 49(2): 197-211.
|
| [26] |
Foschi FG, Bedogni G, Domenicali M, et al. Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study[J]. BMC Gastroenterol, 2018, 18(1): 177.
|
| [27] |
Yang L, Li P, Fu S, et al. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance[J]. Cell Metab, 2010, 11(6): 467-478.
|
| [28] |
Liu H Y, Han J, Cao S Y, et al. Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin[J]. J Biol Chem, 2009, 284(45): 31484-31492.
|
| [29] |
DeFronzo RA, Hompesch M, Kasichayanula S, et al. Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes[J]. Diabetes Care, 2013, 36(10): 3169-3176.
|
| [30] |
Szablewski L. Distribution of glucose transporters in renal diseases[J]. J Biomed Sci, 2017, 24(1): 64.
|
| [31] |
Bank N, Aynedjian HS. Progressive increases in luminal glucose stimulate proximal sodium absorption in normal and diabetic rats[J]. J Clin Invest, 1990, 86(1): 309-316.
|
| [32] |
Kothinti RK, Blodgett AB, North PE, et al. A novel SGLT is expressed in the human kidney[J]. Eur J Pharmacol, 2012, 690(1-3): 77-83.
|
| [33] |
Sotak M, Marks J, Unwin RJ. Putative tissue location and function of the SLC5 family member SGLT3[J]. Exp Physiol, 2017, 102(1): 5-13.
|
| [34] |
Sotak M, Marks J, Unwin R J. Putative tissue location and function of the SLC5 family member SGLT3[J]. Exp Physiol, 2017, 102(1): 5-13.
|
| [35] |
Yan S, Sun F, Li Z, et al. Reduction of intestinal electrogenic glucose absorption after duodenojejunal bypass in a mouse model[J]. Obes Surg, 2013, 23(9): 1361-1369.
|
| [36] |
Hummel CS, Lu C, Liu J, et al. Structural selectivity of human SGLT inhibitors[J]. Am J Physiol Cell Physiol, 2012, 302(2): C373-C382.
|